These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 12741614)

  • 41. Preparation and characterization of domperidone solid dispersions.
    Essa EA; Balata GF
    Pak J Pharm Sci; 2012 Oct; 25(4):783-91. PubMed ID: 23009995
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Investigation of atypical dissolution behavior of an encapsulated amorphous solid dispersion.
    Puri V; Dantuluri AK; Bansal AK
    J Pharm Sci; 2011 Jun; 100(6):2460-8. PubMed ID: 21246560
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Physicochemical characterization of a new crystal form and improvements in the pharmaceutical properties of the poorly water-soluble antiosteoporosis drug 3,9-bis(N,N-dimethylcarbamoy-loxy)-5H-benzofuro[3,2-c]quinoline-6-one (KCA-098) by solid dispersion with hydroxypropylcellulose.
    Yamada T; Saito N; Anraku M; Imai T; Otagiri M
    Pharm Dev Technol; 2000; 5(4):443-54. PubMed ID: 11109244
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Poly(2-Ethyl-2-Oxazoline) as an Alternative to Poly(Vinylpyrrolidone) in Solid Dispersions for Solubility and Dissolution Rate Enhancement of Drugs.
    Fael H; Ràfols C; Demirel AL
    J Pharm Sci; 2018 Sep; 107(9):2428-2438. PubMed ID: 29859957
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Characterization of polymeric dispersions of dimenhydrinate in ethyl cellulose for controlled release.
    Desai J; Alexander K; Riga A
    Int J Pharm; 2006 Feb; 308(1-2):115-23. PubMed ID: 16326055
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effect of the solid-dispersion method on the solubility and crystalline property of tacrolimus.
    Joe JH; Lee WM; Park YJ; Joe KH; Oh DH; Seo YG; Woo JS; Yong CS; Choi HG
    Int J Pharm; 2010 Aug; 395(1-2):161-6. PubMed ID: 20580799
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Preparation and characterization of gliclazide-polyethylene glycol 4000 solid dispersions.
    Patil MP; Gaikwad NJ
    Acta Pharm; 2009 Mar; 59(1):57-65. PubMed ID: 19304558
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Fabrication and evaluation of pH-modulated solid dispersion for telmisartan by spray-drying technique.
    Marasini N; Tran TH; Poudel BK; Cho HJ; Choi YK; Chi SC; Choi HG; Yong CS; Kim JO
    Int J Pharm; 2013 Jan; 441(1-2):424-32. PubMed ID: 23174408
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Solid molecular dispersions of poorly water-soluble drugs in poly(2-hydroxyethyl methacrylate) hydrogels.
    Zahedi P; Lee PI
    Eur J Pharm Biopharm; 2007 Mar; 65(3):320-8. PubMed ID: 17182231
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cefuroxime axetil solid dispersions prepared using solution enhanced dispersion by supercritical fluids.
    Jun SW; Kim MS; Jo GH; Lee S; Woo JS; Park JS; Hwang SJ
    J Pharm Pharmacol; 2005 Dec; 57(12):1529-37. PubMed ID: 16354397
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Use of the co-grinding method to enhance the dissolution behavior of a poorly water-soluble drug: generation of solvent-free drug-polymer solid dispersions.
    Yang C; Xu X; Wang J; An Z
    Chem Pharm Bull (Tokyo); 2012; 60(7):837-45. PubMed ID: 22790815
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Study on the properties of felodipine solid dispersions prepared by different technologies].
    Shi NQ; Zhang H; Zhang Y; Feng B; Li ZQ; Qi XR
    Beijing Da Xue Xue Bao Yi Xue Ban; 2016 Dec; 48(6):1067-1073. PubMed ID: 27987515
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cefuroxime axetil solid dispersion with polyglycolized glycerides for improved stability and bioavailability.
    Dhumal RS; Biradar SV; Aher S; Paradkar AR
    J Pharm Pharmacol; 2009 Jun; 61(6):743-51. PubMed ID: 19505364
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Solid dispersion of carbamazepine in PVP K30 by conventional solvent evaporation and supercritical methods.
    Sethia S; Squillante E
    Int J Pharm; 2004 Mar; 272(1-2):1-10. PubMed ID: 15019063
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A comparative study of spray-dried and freeze-dried hydrocortisone/polyvinyl pyrrolidone solid dispersions.
    Dontireddy R; Crean AM
    Drug Dev Ind Pharm; 2011 Oct; 37(10):1141-9. PubMed ID: 21615280
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Investigating the Potential of Ethyl Cellulose and a Porosity-Increasing Agent as a Carrier System for the Formulation of Amorphous Solid Dispersions.
    Everaerts M; Cools L; Adriaensens P; Reekmans G; Baatsen P; Van den Mooter G
    Mol Pharm; 2022 Aug; 19(8):2712-2724. PubMed ID: 35476407
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Pioglitazone solid dispersion system prepared by spray drying method: in vitro and in vivo evaluation.
    Pokharkar V; Kutwal M; Mandpe L
    PDA J Pharm Sci Technol; 2013; 67(1):23-34. PubMed ID: 23385561
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Changed crystallinity of mebendazole solid dispersion: improved anthelmintic activity.
    García-Rodriguez JJ; de la Torre-Iglesias PM; Vegas-Sánchez MC; Torrado-Durán S; Bolás-Fernández F; Torrado-Santiago S
    Int J Pharm; 2011 Jan; 403(1-2):23-8. PubMed ID: 20934497
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Preparation, characterization and in vitro evaluation of tablets containing microwave-assisted solid dispersions of apremilast.
    Madan JR; Pawar AR; Patil RB; Awasthi R; Dua K
    Polim Med; 2018; 48(1):17-24. PubMed ID: 30657654
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Physicochemical characterization of hot melt extruded bicalutamide-polyvinylpyrrolidone solid dispersions.
    Andrews GP; AbuDiak OA; Jones DS
    J Pharm Sci; 2010 Mar; 99(3):1322-35. PubMed ID: 19798757
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.